Mercy Medical Center Selects MedAssets for Supply Chain Management and Performance Improvement Solutions
19 Novembro 2015 - 11:30AM
MedAssets (NASDAQ:MDAS) today announced that Mercy Medical Center
has selected the company for a wide range of solutions to enhance
operational efficiency and reduce the total cost of care for one of
Iowa's premier healthcare providers.
Under the terms of the multi-year agreement, the Cedar
Rapids-based organization will utilize a breadth of MedAssets
supply chain optimization solutions, including group purchasing
services, pharmacy and spend management analytics, eCommerce
Exchange and Transaction Management Services. To achieve sustained
financial, operational and clinical performance improvement, Mercy
will also engage MedAssets clinical consulting services to align
pricing and utilization practices, clinical operations and payment
to deliver quality patient care.
Areas of emphasis for Mercy initially will focus on optimizing
their procurement process with eCommerce Exchange and Transaction
Management Services, a solution set that optimizes the supply
requisition-to-payment process for improved resource efficiency and
data-driven cost-reduction and management decisions. The eCommerce
platform automates back-office tasks for supply chain transactions
and improves contract compliance, while Transaction Management
Services increases pricing accuracy and operational efficiency
within procurement operations.
"Mercy's new partnership with MedAssets will help us develop and
implement sustainable performance improvement and cost-management
strategies that are essential for continuing our more than
century-long tradition of medical excellence and compassionate
care," said Nathan Van Genderen, executive vice president and chief
financial officer, Mercy Medical Center. "Our ability to leverage
MedAssets technology solutions for streamlining the procurement
process, driving overall operational efficiency and transparency,
and lowering supply costs also ultimately strengthens our ability
to serve the residents of Eastern Iowa."
"We are pleased that Mercy has chosen MedAssets as its
performance management partner. We look forward to our work
together to control costs, improve margins and cash flow, enhance
quality and increase efficiency," said Mike Nolte, president and
chief operating officer, MedAssets. "As providers nationwide seek
to mitigate financial pressures from an increasingly complex
reimbursement structure, MedAsset's expertise, technologies and
services can help Mercy and other organizations realize sustainable
financial and operational gains."
About Mercy Medical Center
For 115 years, Mercy Medical Center has delivered The Mercy
Touch to its patients by partnering the latest technology with
compassionate and high-quality health care. A subsidiary of
MercyCare Service Corporation, Mercy is a fully-accredited 445
licensed-bed regional hospital based in Cedar Rapids, IA. Founded
in 1900 by the Sisters of Mercy, today it offers a wide range of
patient-centered services, including world-class cancer care at the
Hall-Perrine Cancer Center. Mercy has the most advanced private
patient suites in the eastern Iowa Corridor as well as an
established network of primary and urgent care clinics located
throughout Cedar Rapids and surrounding communities. For more
information, visit www.mercycare.org.
About MedAssets
MedAssets (NASDAQ:MDAS) is a healthcare performance improvement
company that combines strategic market insight with rapid
operational execution to help providers sustainably serve the needs
of their communities. More than 4,500 hospitals and 123,000
non-acute healthcare providers rely on our solutions to reduce the
total cost of care, enhance operational efficiency, align clinical
delivery, and improve revenue performance across the System of
CARE. For more information, please visit www.medassets.com.
MDAS/B
CONTACT: Media Contact:
Lea Volpe
678.248.8203
lvolpe@medassets.com
Investor Contact:
Robert Borchert
678.248.8194
rborchert@medassets.com
(MM) (NASDAQ:MDAS)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
(MM) (NASDAQ:MDAS)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024